TauRx Pharma's effort to bring a tau-targeting drug for Alzheimer's disease (AD) to market has been a marathon, with a number of setbacks over the years, but the company reckons it may finally be ...

Investors in TauRx Pharma have exercised warrants worth around $119 million, adding to the biotech's financial resources as it prepares regulatory filings for tau-targeting Alzheimer's drug ...

Hey look at this, a media diet post that’s not months and months since the last one! Phew, it’s a been a long-ass six weeks since the beginning of the year, hasn’t it? Here’s a list of what I’ve been ...

Tau Kappa Epsilon secured second place overall with their month-long entry “Knights and Snow, Wizards Aglow, Hogwarts Shines with Winter’s Snow,” while Sigma Tau Gamma and Alpha Gamma Delta earned ...

After hours: February 12 at 6:10:39 PM EST Loading Chart for DRTS ...